Globe Newswire » trang 174 » Trang Công Nghệ

$Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting$

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Globenewswire -

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

Globenewswire -

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human mul

Globenewswire -

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Globenewswire -

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

Globenewswire -

Yachting: Monaco, 7th 'Superyacht Chef Competition' opens for entries

Globenewswire -

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

Globenewswire -

XEM THÊM TIN MỚI

Nổi bật :

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human mul

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

Yachting: Monaco, 7th 'Superyacht Chef Competition' opens for entries

Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users

So sánh màn hình LG với Samsung và ViewSonic: Đâu là lựa chọn tối ưu?

Mua Đồ Công Nghệ Trả Góp: Hướng Dẫn So Sánh và Chọn Lựa Thông Minh

Lưu ngay cách gỡ bỏ phương thức thanh toán trên iPhone cực hiệu quả

Giải mã thần số học nghề nghiệp 2025 chi tiết, chuẩn xác

Bảng Quy đổi chữ cái thần số học là gì và cách chuyển đổi

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

Defiance Launches SPCU, Delivering 2X Long Exposure to SpaceX in Its First Full Week of Trading

Schneider Electric and Hon Hai Technology Group (Foxconn) announce strategic collaboration to accelerate next-generation AI data centers

Xu hướng nghỉ dưỡng ven biển lên ngôi: Traveloka hé lộ những điểm đến được du khách Việt lựa chọn trong mùa hè 2026

Checkmarx One Achieves Industry’s Highest Scanning Fidelity, Outperforming Both Legacy Tools and AI Models